Agnieszka Pałucha-Poniewiera

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Traumatic Brain Injury

High Fat Diet Induced

Major Depressive Disorder

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Yana Babii, Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Piotr Brański, Andrzej Pilc
Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation. Pharmacological reports : PR (2024)
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Michal Santocki, Yana Babii, Katarzyna Kaczorowska
Partial mGlu 5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice. Pharmacological reports : PR 76 (3) (2024)
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Michal Santocki, Yana Babii, Katarzyna Kaczorowska
Partial mGlu 5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice. Pharmacological reports : PR (2024)
Agnieszka Pałucha-Poniewiera, Anna Rafało-Ulińska, Michal Santocki, Yana Babii, Katarzyna Kaczorowska
Partial mGlu 5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice. Pharmacological reports : PR 76 (3) (2024)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of ( R )-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Anna Rafało-Ulińska, Piotr Brański, Agnieszka Pałucha-Poniewiera
Combined Administration of ( R )-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)